You have been chosen to receive this valuable information.
PHTE
PHTE

 

MOVING PAST THE PATENT CLIFF: QUALITY CONTROL AND GENERIC DRUG PRODUCTION

Brand name medicines are widely recognized and trusted by patients. However, the generic alternative must share the same essential qualities such as intended use, safety, efficacy, quality and other performance characteristics — providing a more cost effective, and equivalent substitute.

If generic drugs are to be widely implemented as an alternative to expensive brand name drugs, patients need to be assured of their effectiveness.

Read our article “Moving Past the Patent Cliff: Quality Control and Generic Drug Production” to find out how generics manufacturers can optimize their drug product’s quality to name-brand alternatives.

phte

 
PHTE
PHTE

Follow:

 		LexisNexis LexisNexis LexisNexis

Privacy Policy | Contact Us

© 2020 PerkinElmer, Inc. All rights reserved.
PerkinElmer, Inc. | 940 Winter Street | Waltham, MA 02451 USA | www.perkinelmer.com

Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.